-
Product Insights
Kazakhstan Combined Cycle Gas Power Plant-ADQ
Kazakhstan Combined Cycle Gas Power Plant-ADQ is a thermal project located in Kazakhstan. The project is owned and being developed by Abu Dhabi National Energy Co; Samruk-Kazyna. The project is expected to come online in 2027. Empower your strategies with our Kazakhstan Combined Cycle Gas Power Plant-ADQ report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase,...
-
Product Insights
ADQ TAQA Samruk-Kazyna Kazakhstan Solar PV park
ADQ TAQA Samruk-Kazyna Kazakhstan Solar PV park is a solar PV project located in Kazakhstan. The project is owned by Abu Dhabi National Energy Co; Samruk-Kazyna and is developed by Abu Dhabi National Energy Co. The project is expected to come online in 2027. Empower your strategies with our ADQ TAQA Samruk-Kazyna Kazakhstan Solar PV park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered...
-
Sector Analysis
Middle East and Africa (MEA) Hydrogen Market Size and Analysis by Application Areas, Upcoming Projects, Policies and Key Players to 2030
Middle East and Africa (MEA) Hydrogen Market Report Overview The active hydrogen capacity in the MEA stood at 0.21 mtpa as of February 2024. The MEA region is emerging as a key player within the emerging hydrogen market. The region has several large-scale low-carbon hydrogen projects in the pipeline that will boost its positioning within the global hydrogen market. Many African countries will be key contributors to the MEA’s emerging hydrogen market including Egypt, Mauritania, Morocco, and South Africa as...
-
Sector Analysis
Mergers and Acquisitions (M&A) in the Contract Manufacturing Industry – Implications and Outlook – 2023 Edition
M and A In Pharmaceutical Contract Manufacturing Industry Report Overview During 2018–22, contract manufacturing organization (CMO) merger and acquisition (M&A) deal activity increased, and the targeted manufacturers have adopted specialized capabilities such as controlled substance and containment manufacture. Despite considerable macroeconomic challenges for pharma manufacturers, 2021–22 witnessed strong M&A activity and CMO valuations, although there was a slight decline in CMO M&A activity in 2022 due to rising inflation and interest rates. The Mergers and Acquisitions (M&A) in the Contract...